ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,198Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 944

$1.8M Total Retail Price of All Prescriptions

Rank: 3 out of 944

558 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 23,470 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
WARFARIN SODIUM 1,227 1,063 1 7
FUROSEMIDE 1,013 867 2 6
DONEPEZIL HCL 923 901 3 24
LEVOTHYROXINE SODIUM 907 758 4 2
NAMENDA 821 796 5 37
AMLODIPINE BESYLATE 727 641 6 5
SERTRALINE HCL 701 585 7 23
SIMVASTATIN 690 557 8 1
LISINOPRIL 630 539 9 3
OMEPRAZOLE 561 494 10 4
MIRTAZAPINE 554 520 11 35
POTASSIUM CHLORIDE 504 427 12 15
METOPROLOL TARTRATE 479 374 13 8
QUETIAPINE FUMARATE 406 369 14 69
HYDROCODONE-ACETAMINOPHEN 400 356 S3 15 10
NIASPAN 396 336 16 76
METOPROLOL SUCCINATE 370 350 17 14
LANTUS 360 198 18 46
FAMOTIDINE 315 285 19 74
ALENDRONATE SODIUM 313 309 20 20
DIVALPROEX SODIUM 312 209 21 85
GABAPENTIN 311 237 22 18
CITALOPRAM HBR 284 254 23 19
RISPERIDONE 262 215 24 78
DIOVAN 251 238 25 38
DIGOXIN 246 234 26 39
VENLAFAXINE HCL ER 229 207 27 84
LIDODERM 220 201 28 73
PREDNISONE 207 181 29 32
CARVEDILOL 201 189 30 30
METFORMIN HCL 195 144 31 12
ALLOPURINOL 189 165 32 22
TAMSULOSIN HCL 186 158 33 27
CLOPIDOGREL 183 152 34 36
IPRATROPIUM-ALBUTEROL 182 138 35 101
PANTOPRAZOLE SODIUM 175 125 36 34
CYMBALTA 175 116 36 75
ATORVASTATIN CALCIUM 173 155 38 13
CARBIDOPA-LEVODOPA 172 161 39 77
POLYETHYLENE GLYCOL 3350 171 152 40 41
SEROQUEL 170 155 41 142
NOVOLOG 167 92 42 93
GLIPIZIDE 161 143 43 51
ADVAIR DISKUS 152 122 44 31
MORPHINE SULFATE ER 151 128 S2 45 80
KLOR-CON M20 146 114 46 71
PLAVIX 144 121 47 55
RANITIDINE HCL 143 133 48 42
LOSARTAN POTASSIUM 131 121 49 16
HYDROCHLOROTHIAZIDE 131 103 49 9
NYSTOP 128 118 51 126
ESCITALOPRAM OXALATE 124 118 52 98
LEVETIRACETAM 122 66 53 97
ENOXAPARIN SODIUM 121 27 54 230
PHENYTOIN SODIUM EXTENDED 118 105 55 168
LEVEMIR 116 98 56 200
PRAVASTATIN SODIUM 115 103 57 17
DIVALPROEX SODIUM ER 114 53 58 170
PAROXETINE HCL 113 105 59 64
SPIRONOLACTONE 112 87 60 44
SEROQUEL XR 111 97 61 270
HUMALOG 110 80 62 109
LEVOFLOXACIN 108 98 63 117
CARBAMAZEPINE 103 101 64 164
TRAMADOL HCL 101 89 65 21
OLANZAPINE 101 72 65 125
KLOR-CON M10 100 84 67 122
TRIAMCINOLONE ACETONIDE 99 64 68 105
BACLOFEN 97 55 69 111
SANTYL 97 69 69 191
NEXIUM 96 74 71 53
ATENOLOL 94 84 72 11
ABILIFY 93 87 73 166
CLONIDINE HCL 92 55 74 67
LAMOTRIGINE 90 44 75 150
ALBUTEROL SULFATE 88 81 76 147
ISOSORBIDE MONONITRATE ER 88 84 76 52
LATANOPROST 88 79 76 202
FLUTICASONE PROPIONATE 84 66 79 40
FENTANYL 78 65 S2 80 57
OXYCODONE-ACETAMINOPHEN 77 67 S2 81 62
NITROGLYCERIN PATCH 77 70 81 143
CALCITONIN-SALMON 76 76 83 277
AMIODARONE HCL 76 59 83 173
HYDRALAZINE HCL 74 47 85 87
CIPROFLOXACIN HCL 70 61 86 90
OXYCODONE HCL 69 33 S2 87 50
EXELON 68 68 88 149
TRAZODONE HCL 66 51 89 45
JANTOVEN 66 66 89 139
SODIUM CHLORIDE 64 43 91 289
IPRATROPIUM BROMIDE 64 49 91 185
OXYBUTYNIN CHLORIDE 62 56 93 94
SPIRIVA 61 55 94 65
METOLAZONE 61 42 94 133
ENALAPRIL MALEATE 60 50 96 43
DILTIAZEM 24HR ER 60 56 96 184
HUMULIN R 59 33 98 242
PROCHLORPERAZINE MALEATE 59 43 98 296
CHLORHEXIDINE GLUCONATE 58 42 100 251
LIPITOR 58 54 100 91
PHENYTOIN 57 20 102 272
METOCLOPRAMIDE HCL 57 30 102 146
NOVOLIN 70-30 56 48 104 195
LEXAPRO 54 51 105 229
VENLAFAXINE HCL 54 50 105 210
CLONIDINE 54 47 105 225
VANCOMYCIN HCL 53 37 108 300
JANUVIA 53 50 108 81
BYSTOLIC 52 50 110 123
ACTONEL 52 51 110 361
LACTULOSE 51 22 112 161
QUINAPRIL HCL 51 51 112 131
FINASTERIDE 51 51 112 83
TRAVATAN Z 50 39 115 197
DILTIAZEM HCL 50 37 115 196
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.